{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:25:03Z","timestamp":1793805903319,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T00:00:00Z","timestamp":1676160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS100761"],"award-info":[{"award-number":["1R01NS100761"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS115860"],"award-info":[{"award-number":["1R01NS115860"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH125979"],"award-info":[{"award-number":["R01MH125979"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61DA048444\u201301"],"award-info":[{"award-number":["R61DA048444\u201301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG3NS115599"],"award-info":[{"award-number":["UG3NS115599"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000900","name":"California Institute for Regenerative Medicine","doi-asserted-by":"publisher","award":["DISC2-14097"],"award-info":[{"award-number":["DISC2-14097"]}],"id":[{"id":"10.13039\/100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bioactmat.2023.02.011","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T18:54:28Z","timestamp":1676660068000},"page":"387-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["In utero delivery of mRNA to the heart, diaphragm and muscle with lipid nanoparticles"],"prefix":"10.1016","volume":"25","author":[{"given":"Kewa","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-6265","authenticated-orcid":false,"given":"Boyan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3530-5993","authenticated-orcid":false,"given":"Diana L.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7815-7337","authenticated-orcid":false,"given":"Niren","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-3627","authenticated-orcid":false,"given":"Aijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioactmat.2023.02.011_bib1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1212\/01.wnl.0000489553.99227.18","article-title":"Practice guideline update summary: corticosteroid treatment of Duchenne muscular dystrophy: report of the guideline development subcommittee of the American academy of neurology","volume":"87","author":"Topaloglu","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.bioactmat.2023.02.011_bib2","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/dmcn.15134","article-title":"Guideline to improve physical function in cerebral palsy: too big to succeed","volume":"64","author":"Romeiser Logan","year":"2022","journal-title":"Dev. Med. Child Neurol."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.02.011_bib3","first-page":"219","article-title":"[Clinical guideline of gene FMR1-associated diseases: fragile X syndrome, primary ovarian insufficiency and tremor-ataxia syndrome]","volume":"142","author":"Mila","year":"2014","journal-title":"Med. Clin."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.02.011_bib4","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41591-018-0184-6","article-title":"In utero CRISPR-mediated therapeutic editing of metabolic genes","volume":"24","author":"Rossidis","year":"2018","journal-title":"Nat. Med."},{"issue":"488","key":"10.1016\/j.bioactmat.2023.02.011_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav8375","article-title":"In utero gene editing for monogenic lung disease","volume":"11","author":"Alapati","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"532","key":"10.1016\/j.bioactmat.2023.02.011_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8980","article-title":"Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with Mucopolysaccharidosis type VII","volume":"12","author":"Nguyen","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.02.011_bib7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41467-019-08852-4","article-title":"Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes","volume":"10","author":"Gan","year":"2019","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.02.011_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/gt.2016.46","article-title":"Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system","volume":"23","author":"DeRosa","year":"2016","journal-title":"Gene Ther."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.02.011_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2023.02.011_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2021.05.007","article-title":"InUtero gene therapy: progress and challenges","author":"Bose","year":"2021","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.02.011_bib11","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1038\/s41467-018-04894-2","article-title":"In utero nanoparticle delivery for site-specific genome editing","volume":"9","author":"Ricciardi","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.02.011_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1028","article-title":"Ionizable lipid nanoparticles for in utero mRNA delivery","volume":"7","author":"Riley","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.02.011_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/gt.2009.115","article-title":"The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors","volume":"17","author":"Endo","year":"2010","journal-title":"Gene Ther."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.02.011_bib14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41591-018-0106-7","article-title":"Fetal gene therapy for neurodegenerative disease of infants","volume":"24","author":"Massaro","year":"2018","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.02.011_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"issue":"52","key":"10.1016\/j.bioactmat.2023.02.011_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.02.011_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid nanoparticles enabling gene therapies: from concepts to clinical utility","volume":"28","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid Therapeut."},{"issue":"47","key":"10.1016\/j.bioactmat.2023.02.011_bib18","doi-asserted-by":"crossref","DOI":"10.3791\/2303-v","article-title":"A mouse model of in utero transplantation","author":"Nijagal","year":"2011","journal-title":"JoVE"},{"issue":"6","key":"10.1016\/j.bioactmat.2023.02.011_bib19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbmt.2016.01.017","article-title":"The intravenous route of injection optimizes engraftment and survival in the murine model of in utero hematopoietic cell transplantation","volume":"22","author":"Boelig","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bioactmat.2023.02.011_bib20","article-title":"Intravenous and intra-amniotic in utero transplantation in the murine model","volume":"140","author":"Ahn","year":"2018","journal-title":"JoVE"},{"issue":"5","key":"10.1016\/j.bioactmat.2023.02.011_bib21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMe2035557","article-title":"A new vaccine to battle covid-19","volume":"384","author":"Haynes","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.02.011_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nbt0918-777","article-title":"Alnylam launches era of RNAi drugs","volume":"36","author":"Garber","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.02.011_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.02.011_bib24","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.02.011_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.bioactmat.2023.02.011_bib26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ymthe.2004.12.018","article-title":"Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency","volume":"11","author":"Zuhorn","year":"2005","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.02.011_bib27","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioactmat.2023.02.011_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-0363-4_6","article-title":"Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications","volume":"1141","author":"Walsh","year":"2014","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.02.011_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ar.1091200104","article-title":"Equivalent ages in mouse and human embryos","volume":"120","author":"Otis","year":"1954","journal-title":"Anat. Rec."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.02.011_bib30","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10237-012-0414-7","article-title":"Biomechanics of early cardiac development","volume":"11","author":"Goenezen","year":"2012","journal-title":"Biomech. Model. Mechanobiol."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.02.011_bib31","doi-asserted-by":"crossref","first-page":"e2853","DOI":"10.1371\/journal.pone.0002853","article-title":"Three-dimensional analysis of vascular development in the mouse embryo","volume":"3","author":"Walls","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bioactmat.2023.02.011_bib32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","article-title":"Lipid nanoparticle technology for therapeutic gene regulation in the liver","volume":"159","author":"Witzigmann","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2023.02.011_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cellimm.2018.01.001","article-title":"Fetal monocytes and the origins of tissue-resident macrophages","volume":"330","author":"Hoeffel","year":"2018","journal-title":"Cell. Immunol."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.02.011_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2017.56","article-title":"Tools for translation: non-viral materials for therapeutic mRNA delivery","volume":"2","author":"Hajj","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bioactmat.2023.02.011_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fnagi.2019.00373","article-title":"Blood-brain barrier and delivery of protein and gene therapeutics to brain","volume":"11","author":"Pardridge","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bioactmat.2023.02.011_bib36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fnins.2014.00404","article-title":"The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history","volume":"8","author":"Saunders","year":"2014","journal-title":"Front. Neurosci."},{"issue":"7501","key":"10.1016\/j.bioactmat.2023.02.011_bib37","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13324","article-title":"Mfsd2a is critical for the formation and function of the blood-brain barrier","volume":"509","author":"Ben-Zvi","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bioactmat.2023.02.011_bib38","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1101\/gad.345505","article-title":"Pax3\/Pax7 mark a novel population of primitive myogenic cells during development","volume":"19","author":"Kassar-Duchossoy","year":"2005","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.bioactmat.2023.02.011_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1097-0177(199811)213:3<309::AID-AJA7>3.0.CO;2-Z","article-title":"Expression of myogenic regulatory factors during muscle development of Xenopus: myogenin mRNA accumulation is limited strictly to secondary myogenesis","volume":"213","author":"Nicolas","year":"1998","journal-title":"Dev. Dynam."},{"issue":"8","key":"10.1016\/j.bioactmat.2023.02.011_bib40","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2014.84","article-title":"In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight","volume":"9","author":"Dahlman","year":"2014","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.02.011_bib41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1083\/jcb.93.2.442","article-title":"Laminin, fibronectin, and collagen in synaptic and extrasynaptic portions of muscle fiber basement membrane","volume":"93","author":"Sanes","year":"1982","journal-title":"J. Cell Biol."},{"issue":"9","key":"10.1016\/j.bioactmat.2023.02.011_bib42","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1161\/ATVBAHA.117.309881","article-title":"In vivo base editing of PCSK9 (proprotein convertase subtilisin\/kexin type 9) as a therapeutic alternative to genome editing","volume":"37","author":"Chadwick","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.bioactmat.2023.02.011_bib43","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41591-018-0184-6","article-title":"In utero CRISPR-mediated therapeutic editing of metabolic genes","volume":"24","author":"Rossidis","year":"2018","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bioactmat.2023.02.011_bib44","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/hep.23481","article-title":"Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo","volume":"51","author":"Paulk","year":"2010","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.bioactmat.2023.02.011_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.3290","article-title":"Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells","volume":"33","author":"Hendel","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.bioactmat.2023.02.011_bib46","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nbt.4005","article-title":"Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing","volume":"35","author":"Yin","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.02.011_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28137-7","article-title":"Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage","volume":"13","author":"Riesenberg","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.02.011_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0963689717728937","article-title":"In utero transplantation of placenta-derived mesenchymal stromal cells for potential fetal treatment of hemophilia A","volume":"27","author":"Kumar","year":"2018","journal-title":"Cell Transplant."},{"issue":"2","key":"10.1016\/j.bioactmat.2023.02.011_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4252\/wjsc.v12.i2.123","article-title":"Clonal isolation of endothelial colony-forming cells from early gestation chorionic villi of human placenta for fetal tissue regeneration","volume":"12","author":"Gao","year":"2020","journal-title":"World J. Stem Cell."},{"issue":"1","key":"10.1016\/j.bioactmat.2023.02.011_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4252\/wjsc.v7.i1.195","article-title":"Early gestation chorionic villi-derived stromal cells for fetal tissue engineering","volume":"7","author":"Lankford","year":"2015","journal-title":"World J. Stem Cell."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X2300049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X2300049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:40:48Z","timestamp":1762785648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X2300049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":50,"alternative-id":["S2452199X2300049X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2023.02.011","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In utero delivery of mRNA to the heart, diaphragm and muscle with lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2023.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}